Dr. Nawid Mohammad Sarwari, MD

Dr. Sarwari practices at The Oncology Institute - Downey Radiation Oncology in Cerritos, California.

Dr. Sarwari's NPI, 1649698630, was assigned on April 7, 2014. Dr. Sarwari graduated from St. George's University School of Medicine in 2014. Dr. Sarwari's California license number on file is A165978.

Dr. Sarwari's primary practice is The Oncology Institute - Downey Radiation Oncology, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 945-8112.

Dr. Sarwari's primary practice is The Oncology Institute - Downey Radiation Oncology in Cerritos, California. Dr. Sarwari is also affiliated with PIH Health Whittier Hospital. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Sarwari to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarwari practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sarwari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sarwari is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sarwari's licenses on file in 2 states: California and Florida.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, neutropenia and purpura and thrombocytopenia among the conditions Dr. Sarwari treats.

CMS data shows 2,407 Medicare services from Dr. Sarwari across 17 procedure codes in 2024, for 205 Medicare patients. Medicare paid $57,742 for them.

CMS counts 205 Medicare patients who saw Dr. Sarwari in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarwari's median patient age at 64, with 61% women.

In 2024, Dr. Sarwari wrote 937 Medicare Part D claims for 233 patients. 69% of them were for generic drugs. CMS names the drug for 665 of them, across 29 drugs with 11 or more claims each, at $1,574,471 in total drug cost. In 2023, CMS named 955 claims across 31 drugs.

Dr. Sarwari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Sarwari, published from 2015 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Bone Marrow. Dr. Sarwari's most frequent co-authors are Preetesh Jain, MD, Zeev Estrov, MD and Hagop M. Kantarjian, MD.

CMS Open Payments shows 1,188 general payments to Dr. Sarwari from 88 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 75% of the total. Pharmacosmos Therapeutics Inc. paid the most, $4,543.

Dr. Sarwari graduated from St. George's University School of Medicine in 2014.

Dr. Sarwari is in network with 16 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.